Inventor · disambiguated record
David G. Washburn
Also filed as: WASHBURN DAVID G · WASHBURN DAVID GLENN
2 granted patents·8 pending applications·1 citations·filing 2005–2023
33Inventor score
Files withGLAXOSMITHKLINE IP DEV LTD4GLAXOSMITHKLINE IP NO 2 LTD3FRAZEE JAMES S2GLAXOSMITHKLINE LLC1
Top patents by PatentIndex Score
10 records- 0161US10450288B2Hydroxy formamide derivatives and their useGLAXOSMITHKLINE IP NO 2 LTD·Filed 2015·Granted Oct 22, 2019·1 cites·40 claims
- 0260US2025368647A1Nitrogen containing condensed 2,3-dihydroquinazolinone compounds as nav1.8 inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2023·Application pending·0 cites
- 0354US2020095217A1Hydroxy formamide derivatives and their useGLAXOSMITHKLINE IP NO 2 LTD·Filed 2019·Application pending·0 cites
- 0450US2024083896A1Nitrogen Containing 2,3-Dihydroquinazolinone Compounds as Nav1.8 InhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2021·Application pending·0 cites
- 0546US2025084112A1Chemical Compounds Useful for Inhibiting Nav1.8 Voltage-Gated Sodium Channels and Treating Nav1.8 Mediated DiseasesGLAXOSMITHKLINE IP DEV LTD·Filed 2021·Application pending·0 cites
- 0645US7816395B2Pyrrolidinone anilines as progesterone receptor modulatorsGLAXOSMITHKLINE LLC·Filed 2007·Granted Oct 19, 2010·0 cites·5 claims
- 0744US2009233955A11H-Pyrrolo[2,3-B]PyridnesFRAZEE JAMES S·Filed 2005·Application pending·0 cites
- 0844US2023103791A12,3-dihydroquinazolin compounds as nav1.8 inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2020·Application pending·0 cites
- 0941US2012238588A11H-Pyrrolo[2,3-B]PyridinesFRAZEE JAMES S·Filed 2012·Application pending·0 cites
- 1030US2018362485A1N-HYDROXYFORMAMIDE COMPOUNDS AND COMPOSITIONS COMPRISING THEM FOR USE AS BMP l, TLL1 AND/OR TLL2 INHIBITORSGLAXOSMITHKLINE IP NO 2 LTD·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David G. Washburn files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →